A recent study revealed that even advanced AI models like ChatGPT struggle with ethical medical decisions, making basic errors in 20% of cases. As AI becomes integral to healthcare, addressing these gaps is critical. Dive into the challenges and solutions for ethical AI in medicine.
Huawei unveiled a new AI computing system designed to rival Nvidia’s top products, signaling fierce competition in the AI hardware market. Launched on July 26, 2025, this system could reshape AI infrastructure for enterprises. Find out how Huawei is positioning itself in the global AI race.
The U.S. government recently announced a sweeping AI Action Plan to bolster innovation and secure its position in the global AI race. With investments exceeding $90 billion in AI infrastructure and energy, this initiative promises to reshape data center growth and promote American AI technology worldwide. Stay tuned for updates on how this plan will…
Google recently unveiled Gemini 2.0, its most advanced AI model yet, featuring enhanced agentic capabilities for developers and enterprises. Alongside new AI video and image generation tools like Veo 2 and Imagen 3, Google is setting new standards in AI performance. Find out how Gemini 2.0 could transform your business in 2025.
DeepSeek’s AI Assistant has surpassed ChatGPT to become the top-rated free app on the U.S. App Store. With superior performance in logic, coding, and question-answering, DeepSeek is redefining the AI chatbot landscape. Explore why this rising star is making waves in the AI industry.
At its Galaxy Unpacked event, Samsung introduced cutting-edge AI features for the upcoming Galaxy S series. These advancements promise intuitive user experiences, from smarter voice assistants to seamless task automation. Learn how Samsung is pushing mobile AI to new heights in 2025.
A breakthrough AI system is transforming cancer immunotherapy by training immune cells to target tumors with unprecedented precision. Developed by a team at Stanford University, the technology designs protein-based “keys” that enable T-cells to attack cancer cells in just weeks. Early trials show a 70% success rate in reducing tumor size in patients with lung…